Current knowledge about Chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME) causes – summary
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.084Keywords
chronic fatigue syndrome, myalgic encephalomyelitis, CFS/ME causes, post-infection fatigue, post viral fatigue, post-covid fatigueAbstract
Chronic Fatigue Syndrome (CFE) is a severe and disabling disease whose etiology has not yet been elucidated. This implies the lack of a specific biomarker for the diagnosis of PE, and no causal treatment. There are a number of diagnostic criteria that facilitate the diagnosis of PE, but it is still a diagnosis with exclusion. This chapter reviews the scientific literature systematically, summarizing the available knowledge about the probable etiology of Chronic Fatigue Syndrome. The current topic of the influence of SARS-Cov-2 virus infection on the development of symptoms of IPC was also taken into account in particular. A clear explanation of the etiology of PE is necessary for the further development of scientific knowledge about the Chronic Fatigue Syndrome.
References
Holmes G. P., Kaplan J. E., Gantz N. M., Komaroff A. L., Schonberger L. B., Straus S. E., Tosato G., Chronic fatigue syndrome: a working case definition, Annals of internal medicine, 108(3), (1988), 387-389.
Fukuda K., Straus S. E., Hickie I., Sharpe M. C., Dobbins J. G., Komaroff A., The chronic fatigue syndrome: a comprehensive approach to its definition and study, Annals of internal medicine, 121(12), (1994), 953-959.
Kurowski M., Kuna P., Zespół przewlekłego zmęczenia, Alergia Astma Immunologia 1997; 2(4): 223-228
Carruthers B. M., van de Sande M. I., De Meirleir K. L., Klimas N. G., Broderick G., Mitchell T., Bateman L., Myalgic encephalomyelitis: international consensus criteria, Journal of internal medicine, 270(4), (2011), 327-338.
Komaroff A. L., Fagioli L. R., Geiger A. M., Doolittle T. H., Lee J., Kornish R. J., Guerriero R. T., An examination of the working case definition of chronic fatigue syndrome, The American journal of medicine, 100(1), (1996), 56-64.
Shepherd D. C., Chaudhuri A., ME/CFS/PVFS: An exploration of the key clinical issues, ME Association, (2019).
Jason L. A., Sunnquist M., Brown A., Evans M., Newton J. L., Are Myalgic Encephalomyelitis and chronic fatigue syndrome different illnesses? A preliminary analysis., Journal of health psychology, 21(1), (2016, 3-15.
Cotler J., Holtzman C., Dudun C., Jason L. A., A brief questionnaire to assess post-exertional malaise, Diagnostics, 8(3), (2018), 66.
Campagnolo N., Johnston S., Collatz A., Staines D., Marshall‐Gradisnik S., Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review, Journal of human nutrition and dietetics, 30(3), (2017), 247-259.
Straus S. E., Komaroff A. L., Wedner H. J., Chronic fatigue syndrome: point and counterpoint, Journal of Infectious Diseases, 170(1), (1994), 1-6.
Gunn W. J., Connell D. B., Randall B., Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study, In Ciba Foundation Symposium 173‐Chronic Fatigue Syndrome: Chronic Fatigue Syndrome: Ciba Foundation Symposium 173, (2007), 83-101
Bombardier C. H., Buchwal, D., Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use, Medical Care, (1996), 924-930.
Lakhan S. E., Kirchgessner, A., Gut inflammation in chronic fatigue syndrome, Nutrition & metabolism, 7(1), (2010), 79.
Fletcher M. A., Zeng X. R., Barnes Z., Levis S., Klimas N. G., Plasma cytokines in women with chronic fatigue syndrome, Journal of translational medicine, 7(1), (2009), 96.
White P. D., Thomas J. M., Amess J., Crawford D. H., Grover S. A., Kangro H. O., Clare A. W., Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever, The British Journal of Psychiatry, 173(6), (1998), 475-481.
Maes M., Mihaylova I., Leunis J. C., Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut–intestinal permeability, Journal of affective disorders, 99(1-3), (2007), 237-240.
Lorusso L., Mikhaylova S. V., Capelli E., Ferrari D., Ngonga G. K., Ricevuti G., Immunological aspects of chronic fatigue syndrome, Autoimmunity reviews, 8(4), (2009), 287-291.
Aaron L. A., Burke M. M., Buchwald D., Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder, Archives of internal medicine, 160(2), (2000), 221-227.
Scully P., McKernan D. P., Keohane J., Groeger D., Shanahan F., Dinan, T. G., Quigley E. M., Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity, The American journal of gastroenterology, 105(10), (2010), 2235.
Clarke G., Quigley E. M., Cryan J. F., Dinan T. G., Irritable bowel syndrome: towards biomarker identification, Trends in molecular medicine, 15(10), (2009), 478-489.
Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T. H., Ehlert U., Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome, Psychoneuroendocrinology, 30(2), (2005), 188-198.
Raber J., Sorg O., Horn T. F. W., Yu N., Koob G. F., Campbell I. L., Bloom F. E., Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function, Brain research reviews, 26(2-3), (1998), 320-326.
Jiménez M. B., Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last, Revista Espanola de Enfermedades Digestivas, 101, (2009), 553-564.
Bailey M. T., Lubach G. R., Coe C. L., Prenatal stress alters bacterial colonization of the gut in infant monkeys, Journal of pediatric gastroenterology and nutrition, 38(4), (2004), 414-421.
Riedel C. U., Foata F., Philipp, D., Adolfsson O., Eikmanns B. J., Blum S., Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation, World journal of gastroenterology: WJG, 12(23), (2006), 3729.
Logan A. C., Rao A. V., Irani D., Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value, Medical hypotheses, 60(6), (2003), 915-923.
Butt H. L., Dunstan R. H., McGregor N. R., Roberts T. K., Bacterial colonosis in patients with persistent fatigue, In Proceedings of the AHMF international clinical and scientific conference, (2001), 1-2.
Sheedy J. R., Wettenhall R. E., Scanlon D., Gooley P. R., Lewis D. P., Mcgrego, N., De Meirleir K. L., Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome, In vivo, 23(4), (2009), 621-628.
Cani P. D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Muccioli G. G., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, (2009).
Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening–Baucke V., Ortner M., Lochs H., Mucosal flora in inflammatory bowel disease, Gastroenterology, 122(1), (2002), 44-54.
Zhou Q., Zhang B., Verne G. N. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome, Pain, 146(1-2), (2009), 41-46.
Lee K. J., Tack J., Altered intestinal microbiota in irritable bowel syndrome, Neurogastroenterology & Motility, 22(5), (2010), 493-498.
Törnblom H., Lindberg G., Nyberg B., Veress B., Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome, Gastroenterology, 123(6), (2002), 1972-1979.
De Giorgio R., Camilleri M., Human enteric neuropathies: morphology and molecular pathology, Neurogastroenterology & Motility, 16(5), (2004), 515-531.
Sido B., Hack V., Hochlehnert A., Lipps H., Herfarth C., Dröge W., Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease, Gut, 42(4), (1998), 485-492.
Maes M., Twisk F. N., Chronic fatigue syndrome: Harvey and Wessely's (bio) psychosocial model versus a bio (psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways, BMC medicine, 8(1), (2010), 35.
Wagner F., Asfar P., Calzia E., Radermacher P., Szabów C., Bench-to-bedside review: Hydrogen sulfide–the third gaseous transmitter: applications for critical care, Critical care, 13(3), (2009), 213.
Reiffenstein R. J., Hulber W. C., Roth S. H., Toxicology of hydrogen sulfide, Annual review of pharmacology and toxicology, 32(1), (1992), 109-134.
Fiorucci S., Distrutti E., Cirino G., Wallace J. L., The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver, Gastroenterology, 131(1), (2006), 259-271.
Schicho R., Krueger D., Zeller F., Von Weyhern C. W. H., Frieling T., KimuranH., Schemann M., Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon, Gastroenterology, 131(5), (2006), 1542-1552.
Myhill S., Booth N. E., McLaren-Howard J., Chronic fatigue syndrome and mitochondrial dysfunction, International journal of clinical and experimental medicine, 2(1), (2009), 1.
Sheedy J. R., Wettenhall R. E., Scanlon D., Gooley P. R., Lewis D. P., Mcgregor N., De Meirleir K. L., Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome, In vivo, 23(4), (2009), 621-628.
Jammes Y., Steinberg, J. G., Mambrini O., Bregeon F., Delliaux S., Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise, Journal of internal medicine, 257(3), (2005), 299-310.
Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder, Neuro endocrinology letters, 30(4), (2009), 470-476.
Komaroff A. L., Bateman L., Will COVID-19 Lead to Myalgic encephalomyelitis/chronic fatigue syndrome?, Frontiers in Medicine, 7, (2021), 1132.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Monika Prylińska-Jaśkowiak, Marcin Kożuchowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 201
Number of citations: 0
